Trial Profile
A Large, International, Multicenter, Non-Interventional, Retrospective Study Assessing the Effectiveness of Subcutaneous and Intravenous Hepatitis B Immunoglobulin to Prevent Reinfection after Liver Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Hepatitis B immune globulin (Primary) ; Hepatitis B immune globulin (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Nov 2017 New trial record